Loading
Latest filing published 18 Mar 2025 for Zomedica Corp., €6,341.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Rodney James Williams has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Zomedica Pharmaceuticals Corp. and Zomedica Corp. We count 14 filings; the first trade dates from 23 March 2018 and the latest from 17 March 2025.
The open-market side counts 2 purchases for €13k alongside 10 sales for €8,214. On balance, insiders were net buyers of €4,469. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises. In 2025 alone, the filings show 2 purchases and no sales.
The record was last updated on 20 March 2025 with an open-market purchase (€6,341) in Zomedica Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 6 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations